1-2 of 2
Dylan Barth, PharmD, BCPS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gilteritinib Remains Clinically Active in Relapsed/Refractory FLT3 Mutated AML Previously Treated with FLT3 inhibitors

Yazan Numan, MD, Zaid Abdel Rahman, MD, Justin Grenet, MD, Stephanie Boisclair, MD, Jan Philipp Bewersdorf, MD, Dylan Barth, PharmD, BCPS, Amer M. Zeidan, MBBS, MHS, Musa Yilmaz, MD, Shira Dinner, MD, Yehuda E. Deutsch, MD, Olga Frankfurt, MD, Mark Litzow, MD, Aref Al-Kali, MD, James M. Foran, MD, Lisa Z. Sproat, MD, Borko Jovanovic, PhD, Naval Daver, MD, Alexander E. Perl, MD, Jessica K. Altman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–7.
https://doi.org/10.1182/blood-2020-137251
Published: 2020
Journal Articles

Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience

Carlos Galvez, MD, Imran Nizamuddin, MD, Emily Tuchman, MD, Peter Doukas, MD, Neha Reddy, MD, Jessica K. Altman, MD, Jane N. Winter, MD, Leo I. Gordon, MD, Dylan Barth, PharmD, BCPS, Nicole Hodgins, Barbara Pro, MD, Shuo Ma, MD PhD, Shira Dinner, MD, Olga Frankfurt, MD, Jayesh Mehta, MD, Seema Singhal, MD, Kehinde Adekola, MBBS,MS, Jonathan Moreira, MD, Sajal D Tanna, MD MPH, Firas Wehbe, MD PhD, Reem Karmali, MDMSc
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–16.
https://doi.org/10.1182/blood-2020-139495
Published: 2020